Prevention of perinatal group B streptococcal infection: Current controversies

W. David Hager, Anne Schuchat, Ronald Gibbs, Richard L Sweet, Philip Mead, John W. Larsen

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Group B streptococcus (GBS) is the most frequent cause of neonatal sepsis in the United States. The Centers for Disease Control and Prevention (CDC) issued guidelines for its prevention in 1996. This article details areas of controversy with those guidelines and offers recommendations for resolution. We recommend that a prevention policy be adopted by all hospitals. If a screening-based policy is chosen, compliance is essential. Penicillin is the antibiotic of choice for GBS prevention. Increasing resistance to clindamycin and erythromycin might eliminate them as alternative choices in patients allergic to penicillin. Group B streptococcal prophylaxis might not be necessary in women who have repeat elective cesarean delivery. In asymptomatic women, a positive urine culture for GBS should be considered clinically equivalent to a positive vaginal or rectal sample for screening. Neonatal sepsis caused by organisms other than GBS must be monitored carefully by all hospitals providing obstetrics services. Copyright (C) 2000 The American College of Obstetricians and Gynecologists.

Original languageEnglish (US)
Pages (from-to)141-145
Number of pages5
JournalObstetrics and Gynecology
Volume96
Issue number1
DOIs
StatePublished - Jul 2000
Externally publishedYes

Fingerprint

Streptococcal Infections
Streptococcus agalactiae
Penicillins
Guidelines
Clindamycin
Erythromycin
Centers for Disease Control and Prevention (U.S.)
Compliance
Obstetrics
Urine
Neonatal Sepsis

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Prevention of perinatal group B streptococcal infection : Current controversies. / Hager, W. David; Schuchat, Anne; Gibbs, Ronald; Sweet, Richard L; Mead, Philip; Larsen, John W.

In: Obstetrics and Gynecology, Vol. 96, No. 1, 07.2000, p. 141-145.

Research output: Contribution to journalArticle

Hager, W. David ; Schuchat, Anne ; Gibbs, Ronald ; Sweet, Richard L ; Mead, Philip ; Larsen, John W. / Prevention of perinatal group B streptococcal infection : Current controversies. In: Obstetrics and Gynecology. 2000 ; Vol. 96, No. 1. pp. 141-145.
@article{51e20eea12944e6e81ad23360d683334,
title = "Prevention of perinatal group B streptococcal infection: Current controversies",
abstract = "Group B streptococcus (GBS) is the most frequent cause of neonatal sepsis in the United States. The Centers for Disease Control and Prevention (CDC) issued guidelines for its prevention in 1996. This article details areas of controversy with those guidelines and offers recommendations for resolution. We recommend that a prevention policy be adopted by all hospitals. If a screening-based policy is chosen, compliance is essential. Penicillin is the antibiotic of choice for GBS prevention. Increasing resistance to clindamycin and erythromycin might eliminate them as alternative choices in patients allergic to penicillin. Group B streptococcal prophylaxis might not be necessary in women who have repeat elective cesarean delivery. In asymptomatic women, a positive urine culture for GBS should be considered clinically equivalent to a positive vaginal or rectal sample for screening. Neonatal sepsis caused by organisms other than GBS must be monitored carefully by all hospitals providing obstetrics services. Copyright (C) 2000 The American College of Obstetricians and Gynecologists.",
author = "Hager, {W. David} and Anne Schuchat and Ronald Gibbs and Sweet, {Richard L} and Philip Mead and Larsen, {John W.}",
year = "2000",
month = "7",
doi = "10.1016/S0029-7844(00)00848-6",
language = "English (US)",
volume = "96",
pages = "141--145",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Prevention of perinatal group B streptococcal infection

T2 - Current controversies

AU - Hager, W. David

AU - Schuchat, Anne

AU - Gibbs, Ronald

AU - Sweet, Richard L

AU - Mead, Philip

AU - Larsen, John W.

PY - 2000/7

Y1 - 2000/7

N2 - Group B streptococcus (GBS) is the most frequent cause of neonatal sepsis in the United States. The Centers for Disease Control and Prevention (CDC) issued guidelines for its prevention in 1996. This article details areas of controversy with those guidelines and offers recommendations for resolution. We recommend that a prevention policy be adopted by all hospitals. If a screening-based policy is chosen, compliance is essential. Penicillin is the antibiotic of choice for GBS prevention. Increasing resistance to clindamycin and erythromycin might eliminate them as alternative choices in patients allergic to penicillin. Group B streptococcal prophylaxis might not be necessary in women who have repeat elective cesarean delivery. In asymptomatic women, a positive urine culture for GBS should be considered clinically equivalent to a positive vaginal or rectal sample for screening. Neonatal sepsis caused by organisms other than GBS must be monitored carefully by all hospitals providing obstetrics services. Copyright (C) 2000 The American College of Obstetricians and Gynecologists.

AB - Group B streptococcus (GBS) is the most frequent cause of neonatal sepsis in the United States. The Centers for Disease Control and Prevention (CDC) issued guidelines for its prevention in 1996. This article details areas of controversy with those guidelines and offers recommendations for resolution. We recommend that a prevention policy be adopted by all hospitals. If a screening-based policy is chosen, compliance is essential. Penicillin is the antibiotic of choice for GBS prevention. Increasing resistance to clindamycin and erythromycin might eliminate them as alternative choices in patients allergic to penicillin. Group B streptococcal prophylaxis might not be necessary in women who have repeat elective cesarean delivery. In asymptomatic women, a positive urine culture for GBS should be considered clinically equivalent to a positive vaginal or rectal sample for screening. Neonatal sepsis caused by organisms other than GBS must be monitored carefully by all hospitals providing obstetrics services. Copyright (C) 2000 The American College of Obstetricians and Gynecologists.

UR - http://www.scopus.com/inward/record.url?scp=0034040496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034040496&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(00)00848-6

DO - 10.1016/S0029-7844(00)00848-6

M3 - Article

C2 - 10862856

AN - SCOPUS:0034040496

VL - 96

SP - 141

EP - 145

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 1

ER -